help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bastard, J.-P.
Right arrow Articles by Hainque, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bastard, J.-P.
Right arrow Articles by Hainque, B.
The Journal of Clinical Endocrinology & Metabolism Vol. 87, No. 5 2084-2089
Copyright © 2002 by The Endocrine Society


Endocrine Care

Adipose Tissue IL-6 Content Correlates with Resistance to Insulin Activation of Glucose Uptake both in Vivo and in Vitro

Jean-Philippe Bastard, Mustapha Maachi, Jeanne Tran van Nhieu, Claude Jardel, Eric Bruckert, André Grimaldi, Jean-Jacques Robert, Jacqueline Capeau and Bernard Hainque

Service de Biochimie et Hormonologie (J.-P.B., M.M., J.C.), Hôpital Tenon-Rothschild, Assistance Publique-Hôpitaux de Paris (AP-HP), 75020 Paris; INSERM U-402, Faculté de Médecine Saint-Antoine (J.-P.B., J.C.), Université Paris VI, 75012 Paris; Département de Pathologie (J.T.V.N.), Hôpital Henri Mondor, AP-HP et Université Paris XII, 94000 Créteil; Service de Biochimie (C.J., B.H.), Hôpital de la Salpêtrière, AP-HP, 75013 Paris; Service d’Endocrinologie et Métabolisme (E.B.), Hôpital de la Pitié, AP-HP, Paris; Service de Diabétologie et Métabolisme (A.G.), Hôpital de la Pitié, AP-HP, 75013 Paris; and Fédération de Pédiatrie (J.-J.R.), Diabète de l’Enfant et de l’Adolescent, Hôpital Necker-Enfants Malades, AP-HP, 75015 Paris, France

Address all correspondence and requests for reprints to: Dr. Jean-Philippe Bastard, M.D., Ph.D., Service de Biochimie et Hormonologie, Hôpital Tenon, 4 rue de la Chine, 75970, Paris Cedex 20, France. E-mail: . jean-philippe.bastard{at}tnn.ap-hop-paris.fr

Abstract

Obesity and type 2 diabetes are associated with insulin resistance, the mechanisms of which remain poorly understood. A significant correlation between circulating IL-6 level and insulin sensitivity has recently been found in humans. Because adipose tissue could be a significant source of IL-6, we analyzed the relationship between the levels of adipose tissue IL-6 and insulin action in vivo, during a hyperinsulinemic normoglycemic clamp, and in vitro by measuring glucose transport in adipocytes from 12 obese subjects with (n = 7) or without (n = 5) diabetes. We observed an inverse correlation between adipose tissue IL-6 content and maximal insulin-responsiveness measured in vivo (P < 0.02) and in vitro (P < 0.02). Conversely, there was no significant correlation between these two later parameters and adipose tissue leptin or tumor necrosis factor-{alpha} protein contents. Furthermore, we showed, for the first time, the presence of immunoreactive IL-6 receptors in the plasma membrane of human abdominal sc adipocytes. This suggests that locally secreted IL-6 could act on adipocytes by an autocrine/paracrine mechanism. In conclusion, increased IL-6 production by sc adipose cells might participate to the insulin-resistant state observed in human obesity.




This article has been cited by other articles:


Home page
Exp PhysiolHome page
S. R. Gray, A. Ratkevicius, H. Wackerhage, P. Coats, and M. A. Nimmo
The effect of interleukin-6 and the interleukin-6 receptor on glucose transport in mouse skeletal muscle
Exp Physiol, August 1, 2009; 94(8): 899 - 905.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
S. J. Peterson, D. H. Kim, M. Li, V. Positano, L. Vanella, L. F. Rodella, F. Piccolomini, N. Puri, A. Gastaldelli, C. Kusmic, et al.
The L-4F mimetic peptide prevents insulin resistance through increased levels of HO-1, pAMPK, and pAKT in obese mice
J. Lipid Res., July 1, 2009; 50(7): 1293 - 1304.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
D.-E. Lee, S. Kehlenbrink, H. Lee, M. Hawkins, and J. S. Yudkin
Getting the message across: mechanisms of physiological cross talk by adipose tissue
Am J Physiol Endocrinol Metab, June 1, 2009; 296(6): E1210 - E1229.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
I. Nieto-Vazquez, S. Fernandez-Veledo, C. de Alvaro, and M. Lorenzo
Dual Role of Interleukin-6 in Regulating Insulin Sensitivity in Murine Skeletal Muscle
Diabetes, December 1, 2008; 57(12): 3211 - 3221.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
R. A. Johnston, T. A. Theman, F. L. Lu, R. D. Terry, E. S. Williams, and S. A. Shore
Diet-induced obesity causes innate airway hyperresponsiveness to methacholine and enhances ozone-induced pulmonary inflammation
J Appl Physiol, June 1, 2008; 104(6): 1727 - 1735.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Cartier, I. Lemieux, N. Almeras, A. Tremblay, J. Bergeron, and J.-P. Despres
Visceral Obesity and Plasma Glucose-Insulin Homeostasis: Contributions of Interleukin-6 and Tumor Necrosis Factor-{alpha} in Men
J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1931 - 1938.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Wu, Z. Ren, M. Pae, W. Guo, X. Cui, A. H. Merrill, and S. N. Meydani
Aging Up-Regulates Expression of Inflammatory Mediators in Mouse Adipose Tissue
J. Immunol., October 1, 2007; 179(7): 4829 - 4839.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
R. A. Johnston, M. Zhu, Y. M. Rivera-Sanchez, F. L. Lu, T. A. Theman, L. Flynt, and S. A. Shore
Allergic Airway Responses in Obese Mice
Am. J. Respir. Crit. Care Med., October 1, 2007; 176(7): 650 - 658.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
K. E. Inouye, H. Shi, J. K. Howard, C. H. Daly, G. M. Lord, B. J. Rollins, and J. S. Flier
Absence of CC Chemokine Ligand 2 Does Not Limit Obesity-Associated Infiltration of Macrophages Into Adipose Tissue
Diabetes, September 1, 2007; 56(9): 2242 - 2250.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
D. M.L. Tsukumo, M. A. Carvalho-Filho, J. B.C. Carvalheira, P. O. Prada, S. M. Hirabara, A. A. Schenka, E. P. Araujo, J. Vassallo, R. Curi, L. A. Velloso, et al.
Loss-of-Function Mutation in Toll-Like Receptor 4 Prevents Diet-Induced Obesity and Insulin Resistance
Diabetes, August 1, 2007; 56(8): 1986 - 1998.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
M. Qatanani and M. A. Lazar
Mechanisms of obesity-associated insulin resistance: many choices on the menu
Genes & Dev., June 15, 2007; 21(12): 1443 - 1455.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. Ishizuka, I. Usui, Y. Kanatani, A. Bukhari, J. He, S. Fujisaka, Y. Yamazaki, H. Suzuki, K. Hiratani, M. Ishiki, et al.
Chronic Tumor Necrosis Factor-{alpha} Treatment Causes Insulin Resistance via Insulin Receptor Substrate-1 Serine Phosphorylation and Suppressor of Cytokine Signaling-3 Induction in 3T3-L1 Adipocytes
Endocrinology, June 1, 2007; 148(6): 2994 - 3003.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. Glund, A. Deshmukh, Y. C. Long, T. Moller, H. A. Koistinen, K. Caidahl, J. R. Zierath, and A. Krook
Interleukin-6 Directly Increases Glucose Metabolism in Resting Human Skeletal Muscle
Diabetes, June 1, 2007; 56(6): 1630 - 1637.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
M. P Corcoran, S. Lamon-Fava, and R. A Fielding
Skeletal muscle lipid deposition and insulin resistance: effect of dietary fatty acids and exercise
Am. J. Clinical Nutrition, March 1, 2007; 85(3): 662 - 677.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
R. A. Mooney
COUNTERPOINT: INTERLEUKIN-6 DOES NOT HAVE A BENEFICIAL ROLE IN INSULIN SENSITIVITY AND GLUCOSE HOMEOSTASIS
J Appl Physiol, February 1, 2007; 102(2): 816 - 818.
[Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
REBUTTAL FROM DRS. PEDERSEN AND FEBBRAIO
J Appl Physiol, February 1, 2007; 102(2): 818 - 818.
[Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
S. A. Shore
Obesity and asthma: lessons from animal models
J Appl Physiol, February 1, 2007; 102(2): 516 - 528.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
B. K. Pedersen, M. A. Febbraio, and R. A. Mooney
Interleukin-6 does/does not have a beneficial role in insulin sensitivity and glucose homeostasis
J Appl Physiol, February 1, 2007; 102(2): 814 - 816.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Corton, J. I. Botella-Carretero, A. Benguria, G. Villuendas, A. Zaballos, J. L. San Millan, H. F. Escobar-Morreale, and B. Peral
Differential Gene Expression Profile in Omental Adipose Tissue in Women with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., January 1, 2007; 92(1): 328 - 337.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
F. L. Lu, R. A. Johnston, L. Flynt, T. A. Theman, R. D. Terry, I. N. Schwartzman, A. Lee, and S. A. Shore
Increased pulmonary responses to acute ozone exposure in obese db/db mice
Am J Physiol Lung Cell Mol Physiol, May 1, 2006; 290(5): L856 - L865.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Mohlig, M. Freudenberg, T. Bobbert, M. Ristow, H. Rochlitz, M. O. Weickert, A. F. H. Pfeiffer, and J. Spranger
Acetylsalicylic Acid Improves Lipid-Induced Insulin Resistance in Healthy Men
J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 964 - 967.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
R. A. Johnston, T. A. Theman, and S. A. Shore
Augmented responses to ozone in obese carboxypeptidase E-deficient mice
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2006; 290(1): R126 - R133.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
O. P. Kristiansen and T. Mandrup-Poulsen
Interleukin-6 and Diabetes: The Good, the Bad, or the Indifferent?
Diabetes, December 1, 2005; 54(suppl_2): S114 - S124.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
M. Cardellini, L. Perego, M. D'Adamo, M. A. Marini, C. Procopio, M. L. Hribal, F. Andreozzi, S. Frontoni, M. Giacomelli, M. Paganelli, et al.
C-174G Polymorphism in the Promoter of the Interleukin-6 Gene Is Associated With Insulin Resistance
Diabetes Care, August 1, 2005; 28(8): 2007 - 2012.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
P. J. Klover, A. H. Clementi, and R. A. Mooney
Interleukin-6 Depletion Selectively Improves Hepatic Insulin Action in Obesity
Endocrinology, August 1, 2005; 146(8): 3417 - 3427.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
A. M. W. Petersen and B. K. Pedersen
The anti-inflammatory effect of exercise
J Appl Physiol, April 1, 2005; 98(4): 1154 - 1162.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
E. W. Petersen, A. L. Carey, M. Sacchetti, G. R. Steinberg, S. L. Macaulay, M. A. Febbraio, and B. K. Pedersen
Acute IL-6 treatment increases fatty acid turnover in elderly humans in vivo and in tissue culture in vitro
Am J Physiol Endocrinol Metab, January 1, 2005; 288(1): E155 - E162.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Zvonic, J. C. Hogan, P. Arbour-Reily, R. L. Mynatt, and J. M. Stephens
Effects of Cardiotrophin on Adipocytes
J. Biol. Chem., November 12, 2004; 279(46): 47572 - 47579.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
T. You, A. S. Ryan, and B. J. Nicklas
The Metabolic Syndrome in Obese Postmenopausal Women: Relationship to Body Composition, Visceral Fat, and Inflammation
J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5517 - 5522.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. E. Trujillo, S. Sullivan, I. Harten, S. H. Schneider, A. S. Greenberg, and S. K. Fried
Interleukin-6 Regulates Human Adipose Tissue Lipid Metabolism and Leptin Production in Vitro
J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5577 - 5582.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
C. R. Bruce and D. J. Dyck
Cytokine regulation of skeletal muscle fatty acid metabolism: effect of interleukin-6 and tumor necrosis factor-{alpha}
Am J Physiol Endocrinol Metab, October 1, 2004; 287(4): E616 - E621.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. N. Vgontzas, E. Zoumakis, H.-M. Lin, E. O. Bixler, G. Trakada, and G. P. Chrousos
Marked Decrease in Sleepiness in Patients with Sleep Apnea by Etanercept, a Tumor Necrosis Factor-{alpha} Antagonist
J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4409 - 4413.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. Rieusset, K. Bouzakri, E. Chevillotte, N. Ricard, D. Jacquet, J.-P. Bastard, M. Laville, and H. Vidal
Suppressor of Cytokine Signaling 3 Expression and Insulin Resistance in Skeletal Muscle of Obese and Type 2 Diabetic Patients
Diabetes, September 1, 2004; 53(9): 2232 - 2241.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
A. S. Ryan and B. J. Nicklas
Reductions in Plasma Cytokine Levels With Weight Loss Improve Insulin Sensitivity in Overweight and Obese Postmenopausal Women
Diabetes Care, July 1, 2004; 27(7): 1699 - 1705.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. N. Fain, A. K. Madan, M. L. Hiler, P. Cheema, and S. W. Bahouth
Comparison of the Release of Adipokines by Adipose Tissue, Adipose Tissue Matrix, and Adipocytes from Visceral and Subcutaneous Abdominal Adipose Tissues of Obese Humans
Endocrinology, May 1, 2004; 145(5): 2273 - 2282.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. E. Wellen, K. T. Uysal, S. Wiesbrock, Q. Yang, H. Chen, and G. S. Hotamisligil
Interaction of Tumor Necrosis Factor-{alpha}- and Thiazolidinedione-Regulated Pathways in Obesity
Endocrinology, May 1, 2004; 145(5): 2214 - 2220.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Mohlig, H. Boeing, J. Spranger, M. Osterhoff, A. Kroke, E. Fisher, M. M. Bergmann, M. Ristow, K. Hoffmann, and A. F. H. Pfeiffer
Body Mass Index and C-174G Interleukin-6 Promoter Polymorphism Interact in Predicting Type 2 Diabetes
J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1885 - 1890.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
P. J. Klover, T. A. Zimmers, L. G. Koniaris, and R. A. Mooney
Chronic Exposure to Interleukin-6 Causes Hepatic Insulin Resistance in Mice
Diabetes, November 1, 2003; 52(11): 2784 - 2789.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
L. B Tanko, Y. Z Bagger, P. Alexandersen, P. J Larsen, C. Christiansen, and for the PERF study group
Central and peripheral fat mass have contrasting effect on the progression of aortic calcification in postmenopausal women
Eur. Heart J., August 2, 2003; 24(16): 1531 - 1537.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
J. M. Fernandez-Real and W. Ricart
Insulin Resistance and Chronic Cardiovascular Inflammatory Syndrome
Endocr. Rev., June 1, 2003; 24(3): 278 - 301.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. J. Senn, P. J. Klover, I. A. Nowak, T. A. Zimmers, L. G. Koniaris, R. W. Furlanetto, and R. A. Mooney
Suppressor of Cytokine Signaling-3 (SOCS-3), a Potential Mediator of Interleukin-6-dependent Insulin Resistance in Hepatocytes
J. Biol. Chem., April 11, 2003; 278(16): 13740 - 13746.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Zvonic, P. Cornelius, W. C. Stewart, R. L. Mynatt, and J. M. Stephens
The Regulation and Activation of Ciliary Neurotrophic Factor Signaling Proteins in Adipocytes
J. Biol. Chem., January 17, 2003; 278(4): 2228 - 2235.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Freemark
Pharmacologic Approaches to the Prevention of Type 2 Diabetes in High Risk Pediatric Patients
J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 3 - 13.
[Full Text] [PDF]


Home page
Diabetes CareHome page
M. Fukui, Y. Kitagawa, N. Nakamura, and T. Yoshikawa
Response to Oncul: Insulin sensitivity in patients with chronic hepatitis C virus infection
Diabetes Care, October 1, 2002; 25(10): 1900 - 1901.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2002 by The Endocrine Society